The impact of prior psychiatric medical treatment on return to work after a diagnosis of breast cancer: A registry based study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1 Citation (Scopus)

Resumé

PURPOSE: Breast cancer and psychiatric disorders negatively impact work life, both positively associated with unemployment and early retirement. Our purpose was to assess whether being prescribed psychiatric medication, 2-4 yrs prior to a diagnosis of breast cancer, could impact the likelihood of returning to work after cancer therapy.

METHODS: 16,868 self-supporting women, diagnosed with breast cancer in Denmark from 2000 to 2012, were identified from a population-based clinical database, then cross-referenced to data held for psychiatric medication usage, sociodemographics, and labour-market participation. The association between historic psychiatric medication and return to work was estimated using a modified Poisson regression model. 'Return to work' was defined as being self-supporting one year after diagnosis of breast cancer.

RESULTS: 16% of our cohort had used psychiatric medical treatment 2-4 years before their diagnosis. Sixty-three per cent of these individuals had returned to work one year later, compared to 69% of the patient group with no prior history of using psychiatric medication treatments. In the fully adjusted model, prior use of psychiatric medication diminished the likelihood of returning to work one year after cancer diagnosis (RR = 0.91 (0.87-0.94)). High income and older age were positively associated with returning to work; negative correlates included those related to disease severity.

CONCLUSIONS: Historic use of psychiatric medication provoked a minor, although statistically significant reduction in the resumption of working life one year after a diagnosis of breast cancer.

IMPLICATIONS FOR CANCER SURVIVORS: Although historic use of psychiatric medication may incur a minor effect on working life, further research is needed on the long-term social consequences for sub-groups.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Public Health
Vol/bind47
Udgave nummer5
Sider (fra-til)519-527
Antal sider9
ISSN1403-4948
DOI
StatusUdgivet - 1 jul. 2019

Fingerprint

Return to Work
Psychiatry
Registries
Breast Neoplasms
Therapeutics
Neoplasms
Unemployment
Retirement
Denmark
Survivors
Databases

Citer dette

@article{881371216a7144d7b2e45abf4ce2071d,
title = "The impact of prior psychiatric medical treatment on return to work after a diagnosis of breast cancer: A registry based study",
abstract = "PURPOSE: Breast cancer and psychiatric disorders negatively impact work life, both positively associated with unemployment and early retirement. Our purpose was to assess whether being prescribed psychiatric medication, 2-4 yrs prior to a diagnosis of breast cancer, could impact the likelihood of returning to work after cancer therapy.METHODS: 16,868 self-supporting women, diagnosed with breast cancer in Denmark from 2000 to 2012, were identified from a population-based clinical database, then cross-referenced to data held for psychiatric medication usage, sociodemographics, and labour-market participation. The association between historic psychiatric medication and return to work was estimated using a modified Poisson regression model. 'Return to work' was defined as being self-supporting one year after diagnosis of breast cancer.RESULTS: 16{\%} of our cohort had used psychiatric medical treatment 2-4 years before their diagnosis. Sixty-three per cent of these individuals had returned to work one year later, compared to 69{\%} of the patient group with no prior history of using psychiatric medication treatments. In the fully adjusted model, prior use of psychiatric medication diminished the likelihood of returning to work one year after cancer diagnosis (RR = 0.91 (0.87-0.94)). High income and older age were positively associated with returning to work; negative correlates included those related to disease severity.CONCLUSIONS: Historic use of psychiatric medication provoked a minor, although statistically significant reduction in the resumption of working life one year after a diagnosis of breast cancer.IMPLICATIONS FOR CANCER SURVIVORS: Although historic use of psychiatric medication may incur a minor effect on working life, further research is needed on the long-term social consequences for sub-groups.",
keywords = "Journal Article, cohort study, return to work, History of psychiatric treatment, breast cancer, Humans, Mental Disorders/drug therapy, Middle Aged, Antipsychotic Agents/therapeutic use, Breast Neoplasms/diagnosis, Denmark, Adult, Female, Registries, Return to Work/statistics & numerical data, Cohort Studies",
author = "Jensen, {Laura Sch{\"a}rfe} and Charlotte Overgaard and Garne, {Jens Peter} and Henrik B{\o}ggild and Kirsten Fonager",
year = "2019",
month = "7",
day = "1",
doi = "10.1177/1403494817722291",
language = "English",
volume = "47",
pages = "519--527",
journal = "Scandinavian Journal of Public Health",
issn = "1403-4948",
publisher = "SAGE Publications",
number = "5",

}

TY - JOUR

T1 - The impact of prior psychiatric medical treatment on return to work after a diagnosis of breast cancer

T2 - A registry based study

AU - Jensen, Laura Schärfe

AU - Overgaard, Charlotte

AU - Garne, Jens Peter

AU - Bøggild, Henrik

AU - Fonager, Kirsten

PY - 2019/7/1

Y1 - 2019/7/1

N2 - PURPOSE: Breast cancer and psychiatric disorders negatively impact work life, both positively associated with unemployment and early retirement. Our purpose was to assess whether being prescribed psychiatric medication, 2-4 yrs prior to a diagnosis of breast cancer, could impact the likelihood of returning to work after cancer therapy.METHODS: 16,868 self-supporting women, diagnosed with breast cancer in Denmark from 2000 to 2012, were identified from a population-based clinical database, then cross-referenced to data held for psychiatric medication usage, sociodemographics, and labour-market participation. The association between historic psychiatric medication and return to work was estimated using a modified Poisson regression model. 'Return to work' was defined as being self-supporting one year after diagnosis of breast cancer.RESULTS: 16% of our cohort had used psychiatric medical treatment 2-4 years before their diagnosis. Sixty-three per cent of these individuals had returned to work one year later, compared to 69% of the patient group with no prior history of using psychiatric medication treatments. In the fully adjusted model, prior use of psychiatric medication diminished the likelihood of returning to work one year after cancer diagnosis (RR = 0.91 (0.87-0.94)). High income and older age were positively associated with returning to work; negative correlates included those related to disease severity.CONCLUSIONS: Historic use of psychiatric medication provoked a minor, although statistically significant reduction in the resumption of working life one year after a diagnosis of breast cancer.IMPLICATIONS FOR CANCER SURVIVORS: Although historic use of psychiatric medication may incur a minor effect on working life, further research is needed on the long-term social consequences for sub-groups.

AB - PURPOSE: Breast cancer and psychiatric disorders negatively impact work life, both positively associated with unemployment and early retirement. Our purpose was to assess whether being prescribed psychiatric medication, 2-4 yrs prior to a diagnosis of breast cancer, could impact the likelihood of returning to work after cancer therapy.METHODS: 16,868 self-supporting women, diagnosed with breast cancer in Denmark from 2000 to 2012, were identified from a population-based clinical database, then cross-referenced to data held for psychiatric medication usage, sociodemographics, and labour-market participation. The association between historic psychiatric medication and return to work was estimated using a modified Poisson regression model. 'Return to work' was defined as being self-supporting one year after diagnosis of breast cancer.RESULTS: 16% of our cohort had used psychiatric medical treatment 2-4 years before their diagnosis. Sixty-three per cent of these individuals had returned to work one year later, compared to 69% of the patient group with no prior history of using psychiatric medication treatments. In the fully adjusted model, prior use of psychiatric medication diminished the likelihood of returning to work one year after cancer diagnosis (RR = 0.91 (0.87-0.94)). High income and older age were positively associated with returning to work; negative correlates included those related to disease severity.CONCLUSIONS: Historic use of psychiatric medication provoked a minor, although statistically significant reduction in the resumption of working life one year after a diagnosis of breast cancer.IMPLICATIONS FOR CANCER SURVIVORS: Although historic use of psychiatric medication may incur a minor effect on working life, further research is needed on the long-term social consequences for sub-groups.

KW - Journal Article

KW - cohort study

KW - return to work

KW - History of psychiatric treatment

KW - breast cancer

KW - Humans

KW - Mental Disorders/drug therapy

KW - Middle Aged

KW - Antipsychotic Agents/therapeutic use

KW - Breast Neoplasms/diagnosis

KW - Denmark

KW - Adult

KW - Female

KW - Registries

KW - Return to Work/statistics & numerical data

KW - Cohort Studies

UR - http://www.scopus.com/inward/record.url?scp=85042128103&partnerID=8YFLogxK

U2 - 10.1177/1403494817722291

DO - 10.1177/1403494817722291

M3 - Journal article

VL - 47

SP - 519

EP - 527

JO - Scandinavian Journal of Public Health

JF - Scandinavian Journal of Public Health

SN - 1403-4948

IS - 5

ER -